|
1
|
Casey SC, Li Y, Fan AC and Felsher DW:
Oncogene withdrawal engages the immune system to induce sustained
cancer regression. J Immunother Cancer. 2:242014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kenny PA, Lee GY and Bissell MJ: Targeting
the tumor microenvironment. Front Biosci. 12:3468–3474. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou K, Cheng T, Zhan J, Peng X, Zhang Y,
Wen J, Chen X and Ying M: Targeting tumor-associated macrophages in
the tumor microenvironment. Oncol Lett. 20:2342020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mantovani A, Sozzani S, Locati M, Allavena
P and Sica A: Macrophage polarization: Tumor-associated macrophages
as a paradigm for polarized M2 mononuclear phagocytes. Trends
Immunol. 23:549–555. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lan C, Huang X, Lin S, Huang H, Cai Q, Wan
T, Lu J and Liu J: Expression of M2-polarized macrophages is
associated with poor prognosis for advanced epithelial ovarian
cancer. Technol Cancer Res Treat. 12:259–267. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kurahara H, Shinchi H, Mataki Y, Maemura
K, Noma H, Kubo F, Sakoda M, Ueno S, Natsugoe S and Takao S:
Significance of M2-polarized tumor-associated macrophage in
pancreatic cancer. J Surg Res. 167:e211–e219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang B, Yao G, Zhang Y and Gao J, Yang B,
Rao Z and Gao J: M2-polarized tumor-associated macrophages are
associated with poor prognoses resulting from accelerated
lymphangiogenesis in lung adenocarcinoma. Clinics (Sao Paulo).
66:1879–1886. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chanmee T, Ontong P, Konno K and Itano N:
Tumor-associated macrophages as major players in the tumor
microenvironment. Cancers (Basel). 6:1670–1690. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qian BZ and Pollard JW: Macrophage
diversity enhances tumor progression and metastasis. Cell.
141:39–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Condeelis J and Pollard JW: Macrophages:
Obligate partners for tumor cell migration, invasion, and
metastasis. Cell. 124:263–266. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pollard JW: Tumour-educated macrophages
promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Valković T, Dobrila F, Melato M, Sasso F,
Rizzardi C and Jonjić N: Correlation between vascular endothelial
growth factor, angiogenesis, and tumor-associated macrophages in
invasive ductal breast carcinoma. Virchows Arch. 440:583–588. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shieh YS, Hung YJ, Hsieh CB, Chen JS, Chou
KC and Liu SY: Tumor-associated macrophage correlated with
angiogenesis and progression of mucoepidermoid carcinoma of
salivary glands. Ann Surg Oncol. 16:751–760. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deryugina EI and Quigley JP: Tumor
angiogenesis: MMP-mediated induction of intravasation- and
metastasis-sustaining neovasculature. Matrix Biol. 44–46. 94–112.
2015.PubMed/NCBI
|
|
15
|
Lin Y, Zhai E, Liao B, Xu L, Zhang X, Peng
S, He Y, Cai S, Zeng Z and Chen M: Autocrine VEGF signaling
promotes cell proliferation through a PLC-dependent pathway and
modulates Apatinib treatment efficacy in gastric cancer.
Oncotarget. 8:11990–12002. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Capece D, Fischietti M, Verzella D,
Gaggiano A, Cicciarelli G, Tessitore A, Zazzeroni F and Alesse E:
The inflammatory microenvironment in hepatocellular carcinoma: A
pivotal role for tumor-associated macrophages. Biomed Res Int.
2013:1872042013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu K, Lin K, Li X, Yuan X, Xu P, Ni P and
Xu D: Redefining tumor-associated macrophage subpopulations and
functions in the tumor microenvironment. Front Immunol.
11:17312020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Feng R, Morine Y, Ikemoto T, Imura S,
Iwahashi S, Saito Y and Shimada M: Nrf2 activation drive
macrophages polarization and cancer cell epithelial-mesenchymal
transition during interaction. Cell Commun Signal. 16:542018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wheeler KC, Jena MK, Pradhan BS, Nayak N,
Das S, Hsu CD, Wheeler DS, Chen K and Nayak NR: VEGF may contribute
to macrophage recruitment and M2 polarization in the decidua. PLoS
One. 13:e01910402018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Linde N, Lederle W, Depner S, van Rooijen
N, Gutschalk CM and Mueller MM: Vascular endothelial growth
factor-induced skin carcinogenesis depends on recruitment and
alternative activation of macrophages. J Pathol. 227:17–28. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Finn RS, Qin S, Ikeda M, Galle PR, Ducreux
M, Kim TY, Kudo M, Breder V, Merle P, Kaseb AO, et al: Atezolizumab
plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J
Med. 382:1894–1905. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheng AL, Qin S, Ikeda M, Galle P, Ducreux
M, Zhu A, Kim TY, Kudo M, Breder V, Merle P, et al: IMbrave150:
Efficacy and safety results from a ph III study evaluating
atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (Sor) as
first treatment (tx) for patients (pts) with unresectable
hepatocellular carcinoma (HCC). Ann Oncol. 30:ix186–ix187. 2019.
View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoshimoto T, Morine Y, Takasu C, Feng R,
Ikemoto T, Yoshikawa K, Iwahashi S, Saito Y, Kashihara H, Akutagawa
M, et al: Blue light-emitting diodes induce autophagy in colon
cancer cells by Opsin 3. Ann Gastroenterol Surg. 2:154–161. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Riabov V, Gudima A, Wang N, Mickley A,
Orekhov A and Kzhyshkowska J: Role of tumor associated macrophages
in tumor angiogenesis and lymphangiogenesis. Front Physiol.
5:752014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsukamoto M, Imai K, Ishimoto T, Komohara
Y, Yamashita YI, Nakagawa S, Umezaki N, Yamao T, Kitano Y, Miyata
T, et al: PD-L1 expression enhancement by infiltrating
macrophage-derived tumor necrosis factor-α leads to poor pancreatic
cancer prognosis. Cancer Sci. 110:310–320. 2019.PubMed/NCBI
|
|
27
|
Wei Y, Zhao Q, Gao Z, Lao XM, Lin WM, Chen
DP, Mu M, Huang CX, Liu ZY, Li B, et al: The local immune landscape
determines tumor PD-L1 heterogeneity and sensitivity to therapy. J
Clin Invest. 129:3347–3360. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shima T, Shimoda M, Shigenobu T, Ohtsuka
T, Nishimura T, Emoto K, Hayashi Y, Iwasaki T, Abe T, Asamura H and
Kanai Y: Infiltration of tumor-associated macrophages is involved
in tumor programmed death-ligand 1 expression in early lung
adenocarcinoma. Cancer Sci. 111:727–738. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lai YS, Wahyuningtyas R, Aui SP and Chang
KT: Autocrine VEGF signalling on M2 macrophages regulates PD-L1
expression for immunomodulation of T cells. J Cell Mol Med.
23:1257–1267. 2019.PubMed/NCBI
|
|
30
|
Sica A and Mantovani A: Macrophage
plasticity and polarization: In vivo veritas. J Clin Invest.
122:787–795. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mantovani A, Biswas SK, Galdiero MR, Sica
A and Locati M: Macrophage plasticity and polarization in tissue
repair and remodelling. J Pathol. 229:176–185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Petty AJ and Yang Y: Tumor-associated
macrophages: Implications in cancer immunotherapy. Immunotherapy.
9:289–302. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hughes R, Qian BZ, Rowan C, Muthana M,
Keklikoglou I, Olson OC, Tazzyman S, Danson S, Addison C, Clemons
M, et al: Perivascular M2 macrophages stimulate tumor relapse after
chemotherapy. Cancer Res. 75:3479–3491. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Osterberg N, Ferrara N, Vacher J, Gaedicke
S, Niedermann G, Weyerbrock A, Doostkam S, Schaefer HE, Plate KH
and Machein MR: Decrease of VEGF-A in myeloid cells attenuates
glioma progression and prolongs survival in an experimental glioma
model. Neuro Oncol. 18:939–949. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Min AKT, Mimura K, Nakajima S, Okayama H,
Saito K, Sakamoto W, Fujita S, Endo H, Saito M, Saze Z, et al:
Therapeutic potential of anti-VEGF receptor 2 therapy targeting for
M2-tumor-associated macrophages in colorectal cancer. Cancer
Immunol Immunother. 70:289–298. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chu M, Xu L, Zhang MB, Chu ZY and Wang YD:
Role of baicalin in anti-influenza virus A as a potent inducer of
IFN-gamma. Biomed Res Int. 2015:2636302015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu FY, Huang SG, Zhang HY, Chi HG, Zou Y,
Lu RX and Zheng XB: Effect of baicalin on signal transduction and
activating transcription factor expression in ulcerative colitis
patients. Zhongguo Zhong Xi Yi Jie He Za Zhi. 35:419–424. 2015.(In
Chinese). PubMed/NCBI
|
|
38
|
Zhang CL, Zhang S, He WX, Lu JL, Xu YJ,
Yang JY and Liu D: Baicalin may alleviate inflammatory infiltration
in dextran sodium sulfate-induced chronic ulcerative colitis via
inhibiting IL-33 expression. Life Sci. 186:125–132. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kessler T, Sahm F, Blaes J, Osswald M,
Rübmann P, Milford D, Urban S, Jestaedt L, Heiland S, Bendszus M,
et al: Glioma cell VEGFR-2 confers resistance to chemotherapeutic
and antiangiogenic treatments in PTEN-deficient glioblastoma.
Oncotarget. 6:31050–31068. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Faes S, Santoro T, Demartines N and
Dormond O: Evolving significance and future relevance of
anti-angiogenic activity of mTOR inhibitors in cancer therapy.
Cancers (Basel). 9:1522017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mercurio A, Lipscomb E and Bachelder R:
Non-angiogenic functions of VEGF in breast cancer. J Mammary Gland
Biol Neoplasia. 10:283–290. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yao X, Tu Y, Xu Y, Guo Y, Yao F and Zhang
X: Endoplasmic reticulum stress-induced exosomal miR-27a-3p
promotes immune escape in breast cancer via regulating PD-L1
expression in macrophages. J Cell Mol Med. 24:9560–9573. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li D, Sun FF, Wang D, Wang T, Peng JJ,
Feng JQ, Li H, Wang C, Zhou DJ, Luo H, et al: Programmed death
ligand-1 (PD-L1) regulated by NRF-2/MicroRNA-1 regulatory axis
enhances drug resistance and promotes tumorigenic properties in
sorafenib-resistant hepatoma cells. Oncol Res. 28:467–481. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Schmidinger M: Clinical decision-making
for immunotherapy in metastatic renal cell carcinoma. Curr Opin
Urol. 28:29–34. 2018. View Article : Google Scholar : PubMed/NCBI
|
